<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ingle P</submitter><funding>Swiss National Science Foundation</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>8123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6544763</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Understanding the molecular pathogenesis of Clostridioides difficile has relied on the use of ermB-based mutagens in erythromycin-sensitive strains. However, the repeated subcultures required to isolate sensitive variants can lead to the acquisition of ancillary mutations that affect phenotype, including virulence. CRISPR-Cas9 allows the direct selection of mutants, reducing the number of subcultures and thereby minimising the likelihood of acquiring additional mutations. Accordingly, CRISPR-Cas9 was used to sequentially remove from the C. difficile 630 reference strain (NCTC 13307) two ermB genes and pyrE. The genomes of the strains generated (630Δerm* and 630Δerm*ΔpyrE, respectively) contained no ancillary mutations compared to the NCTC 13307 parental strain, making these strains the pre</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Generation of a fully erythromycin-sensitive strain of Clostridioides difficile using a novel CRISPR-Cas9 genome editing system.</pubmed_title><pmcid>PMC6544763</pmcid><funding_grant_id>BB/L01081X/1</funding_grant_id><funding_grant_id>147603</funding_grant_id><funding_grant_id>BB/L502030/1</funding_grant_id><funding_grant_id>BB/M012336/1</funding_grant_id><funding_grant_id>NIHR-INF-0155</funding_grant_id><funding_grant_id>BB/K00283X/1</funding_grant_id><funding_grant_id>BB/L013940/1</funding_grant_id><funding_grant_id>G0601176</funding_grant_id><pubmed_authors>Ingle P</pubmed_authors><pubmed_authors>Cockayne A</pubmed_authors><pubmed_authors>Kuehne SA</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Jiang W</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Groothuis D</pubmed_authors><pubmed_authors>Rowe P</pubmed_authors><pubmed_authors>Humphreys CM</pubmed_authors><pubmed_authors>Minton NP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Generation of a fully erythromycin-sensitive strain of Clostridioides difficile using a novel CRISPR-Cas9 genome editing system.</name><description>Understanding the molecular pathogenesis of Clostridioides difficile has relied on the use of ermB-based mutagens in erythromycin-sensitive strains. However, the repeated subcultures required to isolate sensitive variants can lead to the acquisition of ancillary mutations that affect phenotype, including virulence. CRISPR-Cas9 allows the direct selection of mutants, reducing the number of subcultures and thereby minimising the likelihood of acquiring additional mutations. Accordingly, CRISPR-Cas9 was used to sequentially remove from the C. difficile 630 reference strain (NCTC 13307) two ermB genes and pyrE. The genomes of the strains generated (630Δerm* and 630Δerm*ΔpyrE, respectively) contained no ancillary mutations compared to the NCTC 13307 parental strain, making these strains the pre</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-05-07T02:08:50.495Z</modification><creation>2019-07-24T07:07:55Z</creation></dates><accession>S-EPMC6544763</accession><cross_references><pubmed>31148548</pubmed><doi>10.1038/s41598-019-44458-y</doi></cross_references></HashMap>